Provided By GlobeNewswire
Last update: Oct 28, 2024
– National campaign to elevate experiences from the recurrent pericarditis community and empower patients to seek care –
LONDON, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a commercial-stage biopharmaceutical company, with a pipeline of immune-modulating assets designed to target a spectrum of cardiovascular and autoimmune diseases, today announced a partnership with GRAMMY Award-winning singer-songwriter, Carly Pearce, as part of its Life DisRPted campaign focused on promoting early diagnosis and treatment of recurrent pericarditis. Pearce announced that she had been diagnosed with the chronic autoinflammatory disease while on tour in May 2024.
Read more at globenewswire.com27.74
+0.77 (+2.86%)
Find more stocks in the Stock Screener
Let's have a look at the gap up and gap down stocks in today's session.